NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use
- DOI
- 10.1038/s41393-026-01262-6
- Published
- 2026-08-20
- Container
- Spinal Cord
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41393-026-01262-6,
title = {NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use},
author = {Elle E. M. Scheijen and Naomi Veeningen and Femke Cornelissen and Niels Hellings and David M Wilson},
year = {2026},
journal = {Spinal Cord},
doi = {10.1038/s41393-026-01262-6},
url = {https://doi.org/10.1038/s41393-026-01262-6}
}RIS
TY - JOUR TI - NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use AU - Elle E. M. Scheijen AU - Naomi Veeningen AU - Femke Cornelissen AU - Niels Hellings AU - David M Wilson PY - 2026 JO - Spinal Cord DO - 10.1038/s41393-026-01262-6 UR - https://doi.org/10.1038/s41393-026-01262-6 ER -
APA
Scheijen, E. E. M., Veeningen, N., Cornelissen, F., Hellings, N., & Wilson, D. M. (2026). NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use. Spinal Cord. https://doi.org/10.1038/s41393-026-01262-6
Source records
- crossref · retrieved 2026-09-25T13:55:23.545Z